MedPath

REACTINE CHEWABLE TABLETS 5 MG

REACTINE CHEWABLE TABLETS 5 MG

Discontinued
DIN Number

02295059

Drug Class

Human

Market Date

N/A

Company
HC

mcneil consumer healthcare division of johnson & johnson inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02295059
AIG Number0122686002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R06AE07 CETIRIZINE
Product Specifications
Dosage FormTablet (Chewable)
Route of AdministrationOral
AHFS Classification04:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CETIRIZINE HYDROCHLORIDEActive
Strength: 5 MG
Monograph: CETIRIZINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.